RecruitingN/Aketamine

Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments

Sponsored by Neuronetics

NCT ID
NCT06997549
Target Enrollment
12,000 participants
Start Date
2025-05-15
Est. Completion
2035-12

About This Study

The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness

Conditions Studied

DepressionOCDAnxiety Depression

Interventions

  • •Patients treated with NeuroStar TMS
  • •Patients treated with Esketamine

Eligibility

Age:5 Years - 100 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Male or female reported in database and not an invalid entry
* Age reported and not an invalid entry
* Treatment date in 2011 or later.

Exclusion Criteria:

• Incomplete information on treatment parameters

Study Locations (1)

Neuronetics
Malvern, Pennsylvania, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Neha Goyal
CONTACT
7635281599neha.goyal@neurostar.com
Eleanor Cole, PhD
CONTACT
415-724-7960Eleanor.cole@neurostar.com
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments | Huxley